Navigation Links
Study Published in Otology & Neurotology Shows Benefits of Cochlear Implant Sound Processor with Dual-Microphone Technology
Date:11/5/2012

CENTENNIAL, Colo., Nov. 5, 2012 /PRNewswire/ --  Cochlear Americas, the world's leading implantable hearing solutions company, announced today the results of a new study published in Otology & Neurotology, which demonstrates the benefit of the dual-microphone technology in the Cochlear Nucleus 5 CP810 Sound Processor.  The study illustrates how the Nucleus 5 sound processor provides significantly better speech recognition in quiet and in noise when compared with the performance of the Cochlear Nucleus® Freedom™ processor. 

"Cochlear implants are highly successful devices for many adults who have severe to profound hearing loss; however, most recipients continue to experience difficulty understanding speech in the presence of competing noise," said Jace Wolfe , Ph.D., CCC-A, Hearts for Hearing, Oklahoma City, lead study investigator. "Results from this study indicate that the Nucleus 5 sound processor provided a significant improvement in speech recognition relative to the performance with the previous generation sound processor."

The Nucleus 5 sound processor contains two microphones, which are precisely calibrated and phase matched to +/- 1 dB tolerance to ensure accuracy and consistency.  With two microphones the Nucleus 5 provides a directional mode called "SmartSound® zoom" technology, which significantly lessens competing background noises, as well as enhancements in the signal processing chip to enhance speech recognition in quiet and noise.

"This study demonstrates our commitment to continually improving the experience of our recipients," said Christine Menapace, MA, CCC-A, Vice President of Clinical, Training and Education at Cochlear. "Every new generation of the Nucleus Sound Processor has been backwards-compatible, enabling our cochlear implant users to upgrade to the latest technological improvements, such as the dual-microphone 'SmartSound® zoom' technology."

To hear the benefits of the dual microphones on the Nucleus 5 sound processor first-hand, visit http://www.cochlearamericas.com/performance or download the "Dual Mic Zoom Technology from Cochlear" iPad app for free from iTunes®.

About the Study
This study – "Benefit of a Commercially Available Cochlear Implant Processor With Dual-Microphone Beamforming: A Multi-Center Study" – was conducted across four cochlear implant clinics in the United States. Thirty-five adult Nucleus recipients were upgraded to the Nucleus 5 Sound Processor and speech recognition was assessed with CNC monosyllabic words in quiet and sentences in noise from the BKB-SIN (Bamford-Kowal-Bench Sentences in Noise) test. The primary objective of the study was to compare speech recognition in quiet and in noise for the Nucleus Freedom and Nucleus 5 CP810 Sound Processors set to the manufacturer's default user programs for quiet and noisy environments.

About Cochlear Implants
Cochlear implants are a proven medical option for infants as young as 12 months old with profound hearing loss in both ears, children aged two and older with severe-to-profound hearing loss, and adults with moderate-to-profound hearing loss in both ears. They are electronic devices, which bypass damaged hair cells in the inner ear, or cochlea, and stimulate the hearing nerve directly.

About Cochlear
Cochlear is the world leader in advanced hearing technologies. Since launching the first multichannel cochlear implant system 30 years ago, Cochlear Limited and its U.S. headquarters have brought the miracle of sound to more than 250,000 people with hearing loss across the globe. For more information about Cochlear Americas products, please visit www.cochlearamericas.com.


'/>"/>
SOURCE Cochlear Americas
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... ... of the Best Places to Work in the Research Triangle for 2017. , ... nominated, a company had to meet a threshold in employee participation--a percentage that ...
(Date:9/20/2017)... ... 2017 , ... Demand generation pioneer True Influence has announced ... The Marketing Tech Conference October 2–4, at the Hynes Convention Center in Boston, ... representing such thought-leading companies as JP Morgan Chase, GE Digital, and Dun & ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute (HSI) ... HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to assist ... offering these discounted prices to all businesses and government agencies – whether or not ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm ... Friday, September 8, and Monday, September 11, off work and rolled up their sleeves ... before heading to local homes to start the process of rebuilding. , CORDA founder ...
Breaking Medicine News(10 mins):